News
-
23.06.2009
Salvacyl®, developed by Debiopharm, is launched in two European countries - a new therapeutic avenue for the treatment of sexual deviations - -
18.06.2009
Debiopharm Group and Moffitt Cancer Center sign development and commercialisation agreement for small molecule Debio 0928 in early preclinical development for treatment of solid tumours - A novel drug with potential to block cancer cell proliferation
Login Form
Home
| Credits |
PhotographsPhotograph of mountains & lake on home page by Jacques Straesslé (copyright Debiopharm). Various scenery and artistic lab photographs by Daniel Choinière (copyright Debiopharm). Scenes from Debio RP by Heinz Preisig (copyright Debiopharm).
The graphic content of the website was designed by François Grieshaber, fgdesign . WebsiteThe technological integration was realised by inetis. |